Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MT3 |
| Upstream (Parents) |
|---|
| (<<) ACTC1 → MT3 |
| (<<) ALPP → MT3 |
| (<<) ANGPTL4 → MT3 |
| (<<) CASKIN1 → MT3 |
| (<<) CDH22 → MT3 |
| (<<) CHST7 → MT3 |
| (<<) CHSY1 → MT3 |
| (<<) CNFN → MT3 |
| (<<) CRNN → MT3 |
| (<<) CSGALNACT2 → MT3 |
| (<<) EPHA4 → MT3 |
| (<<) FOSL1 → MT3 |
| (<<) IL1F5 → MT3 |
| (<<) INE1 → MT3 |
| (<<) LCE3D → MT3 |
| (<<) PLCD3 → MT3 |
| (<<) T → MT3 |
| (<<) TNFRSF1A → MT3 |
| (<<) UCN2 → MT3 |
| Downstream (Children) |
|---|
| MT3 → APLN (>>) |
| MT3 → BZW2 (>>) |
| MT3 → IVL (>>) |
| MT3 → MYH14 (>>) |
| MT3 → MYL5 (>>) |
| MT3 → PDK1 (>>) |
